Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Atogepant for Treatment-resistant Migraine in Real-world Clinical Practice: 12-month Result

NCT07699549 is registered in ClinicalTrials.gov with Fundación de Investigación Biomédica - Hospital Universitario de La Princesa as lead sponsor.

NCT NCT07699549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07699549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Atogepant for Treatment-resistant Migraine in Real-world Clinical Practice: 12-month Result
Lead sponsor
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Phase
Observational
Overall status
Completed
Start date
June 1, 2024
Completion date
March 1, 2026
Enrollment
513 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

headache, headache (migraine), migraine, migraine disability, migraine disease, migraine disorder, migraine headache